The Federal Circuit’s recent decision in Aortic Innovations LLC v. Edwards Lifesciences Corporation, No. 2024-1145 (Fed. Cir. Oct. 27, 2025) is a bit of a cautionary tale for patent drafters. It is ...

The burden of drafting patent applications with sufficient support for antibody claims is not likely to lessen any time soon. The courts and the scientific community are in agreement that antibody ...

“Approaching examiners with humility and gratitude is like a magic key to unlocking our ability to see inventions the ways others – such as opposing counsel – may interpret them.” The dramatic ending ...

The US Patent and Trademark Office (USPTO) recently launched the Streamlined Claim Set Pilot Program — a new initiative designed to expedite patent examination for eligible patent application by ...

This is the second post about the DTSA case Insulet Corp. v. EOFlow, Co., No. 2025-1807 (Fed. Cir. May 28, 2026). The last post covered the merits. This one is about appellate jurisdiction, and about ...